We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Call for Clarification of FDA’s Postapproval Change Guidance
Drugmakers Call for Clarification of FDA’s Postapproval Change Guidance
Leading drug companies called for tweaks in the FDA’s draft guidance on postapproval changes for drugs to help clarify info and better align with ICH guidelines.